We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+31.49%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$48.8M
Cap. Flow
-$3.25M
Cap. Flow %
-1.22%
Top 10 Hldgs %
41.05%
Holding
154
New
18
Increased
47
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
CTSO icon
Cytosorbents Corp
CTSO
+$2.09M
2
FTCS icon
First Trust Capital Strength ETF
FTCS
+$1.73M
3
IRM icon
Iron Mountain
IRM
+$870K
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$743K
5
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$566K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$2.51M
2
ATRS
Antares Pharma, Inc.
ATRS
+$1.75M
3
BOC icon
Boston Omaha
BOC
+$1.17M
4
XYZ
Block Inc
XYZ
+$1.15M
5
EXEL icon
Exelixis
EXEL
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 22.92%
2 Healthcare 20.44%
3 Financials 15.49%
4 Consumer Discretionary 6%
5 Real Estate 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
101
State Street SPDR S&P Biotech ETF
XBI
$10B
$432K 0.16%
3,840
+225
+6% +$22.2K
ETX
102
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
$426K 0.16%
20,745
– –
PFE icon
103
Pfizer
PFE
$148B
$425K 0.16%
13,281
– –
GILD icon
104
Gilead Sciences
GILD
$161B
$421K 0.16%
+5,534
New +$424K
BAC icon
105
Bank of America
BAC
$439B
$404K 0.15%
17,380
-8,735
-33% -$206K
AXP icon
106
American Express
AXP
$232B
$396K 0.15%
4,209
-48
-1% -$4.42K
EPD icon
107
Enterprise Products Partners
EPD
$82.1B
$380K 0.14%
21,212
+4,000
+23% +$71.5K
EZM icon
108
WisdomTree US MidCap Fund
EZM
$952M
$369K 0.14%
11,515
-3,210
-22% -$97.8K
SASR
109
DELISTED
Sandy Spring Bancorp Inc
SASR
$351K 0.13%
14,825
+3,715
+33% +$88.3K
LLY icon
110
Eli Lilly
LLY
$1.06T
$343K 0.13%
2,099
+485
+30% +$74.4K
THW
111
abrdn World Healthcare Fund
THW
$545M
$331K 0.12%
23,000
– –
V icon
112
Visa
V
$690B
$329K 0.12%
1,696
– –
FUN icon
113
Cedar Fair
FUN
$1.61B
$326K 0.12%
11,570
– –
FEX icon
114
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.6B
$322K 0.12%
5,415
-1,675
-24% -$93.1K
CVS icon
115
CVS Health
CVS
$124B
$305K 0.11%
4,732
+105
+2% +$6.61K
GLW icon
116
Corning
GLW
$136B
$301K 0.11%
11,735
-9,000
-43% -$204K
TSLA icon
117
Tesla
TSLA
$1.26T
$287K 0.11%
+3,840
New +$208K
IYF icon
118
iShares US Financials ETF
IYF
$4.61B
$282K 0.11%
5,130
-4,870
-49% -$260K
SGOL icon
119
abrdn Physical Gold Shares ETF
SGOL
$7.24B
$274K 0.1%
16,070
– –
DHR icon
120
Danaher
DHR
$140B
$262K 0.1%
+1,669
New +$240K
MAC icon
121
Macerich
MAC
$6.9B
$261K 0.1%
+30,000
New +$232K
APA icon
122
APA Corp
APA
$12.8B
$260K 0.1%
+20,000
New +$228K
TSM icon
123
TSMC
TSM
$2.18T
$259K 0.1%
+4,553
New +$240K
ADP icon
124
Automatic Data Processing
ADP
$109B
$257K 0.1%
1,721
– –
BALL icon
125
Ball Corp
BALL
$16.8B
$254K 0.1%
3,600
– –
3 4
5
6 7

Similar funds

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
TVAMP
Tennessee Valley Asset Management Partners Knoxville, Tennessee $757M AUM 14.19% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $754M AUM 60.05% 1-Year Est. Return

Sargent Investment Group's Q2 2020 Portfolio in Review

As of Q2 2020, Sargent Investment Group held 154 positions worth $266M, up 22% from $217M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sargent Investment Group's Q2 2020 filing shows 18 new, 47 increased, 47 reduced and 7 closed positions. Its largest new stake was Gilead Sciences: 5,534 shares worth $421K. The largest sale was Abbott, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Sargent Investment Group's largest Q2 2020 buy was Gilead Sciences: 5,534 shares worth $421K.
  • Sargent Investment Group added most to Cytosorbents Corp in Q2 2020, an estimated $2.09M increase.
  • Sargent Investment Group's biggest Q2 2020 reduction was Abbott, cutting an estimated $2.51M.
  • Sargent Investment Group fully exited WBI BullBear Global Income ETF in Q2 2020, selling an estimated $582K.
  • Sargent Investment Group's ten largest holdings make up 41% of its $266M portfolio in Q2 2020.
  • Sargent Investment Group opened 18 new positions and closed 7 in Q2 2020.
  • Sargent Investment Group's portfolio value rose 22% quarter-over-quarter to $266M.

Based on Sargent Investment Group's 13F filing for Q2 2020, filed 11 Aug 2020.